Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2417981
Max Phase: Preclinical
Molecular Formula: C33H54N4O11S3
Molecular Weight: 779.01
Molecule Type: Small molecule
Associated Items:
ID: ALA2417981
Max Phase: Preclinical
Molecular Formula: C33H54N4O11S3
Molecular Weight: 779.01
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC[C@@H]1C[C@@H](C(=O)NC([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)SCCOCCSCC(=O)N[C@H](CO)[C@H](O)c2ccc([N+](=O)[O-])cc2)N(C)C1
Standard InChI: InChI=1S/C33H54N4O11S3/c1-5-6-20-15-24(36(3)16-20)32(44)35-26(31-29(42)28(41)30(43)33(48-31)49-4)19(2)51-14-12-47-11-13-50-18-25(39)34-23(17-38)27(40)21-7-9-22(10-8-21)37(45)46/h7-10,19-20,23-24,26-31,33,38,40-43H,5-6,11-18H2,1-4H3,(H,34,39)(H,35,44)/t19-,20-,23-,24+,26?,27-,28+,29-,30-,31-,33-/m1/s1
Standard InChI Key: RUZLHYIFKXZKEC-LZXSUSGUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 779.01 | Molecular Weight (Monoisotopic): 778.2951 | AlogP: 0.75 | #Rotatable Bonds: 21 |
Polar Surface Area: 224.19 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.13 | CX Basic pKa: 7.80 | CX LogP: 0.61 | CX LogD: 0.07 |
Aromatic Rings: 1 | Heavy Atoms: 51 | QED Weighted: 0.05 | Np Likeness Score: -0.14 |
1. Berkov-Zrihen Y, Green KD, Labby KJ, Feldman M, Garneau-Tsodikova S, Fridman M.. (2013) Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: antimicrobial activity, in vitro inhibition of translation, and drug resistance., 56 (13): [PMID:23786357] [10.1021/jm400707f] |
Source(1):